Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,385 | 817 | 96.5% |
| Education | $315.92 | 14 | 2.9% |
| Gift | $59.40 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,732 | 216 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,072 | 91 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $816.29 | 59 | $0 (2022) |
| Amgen Inc. | $770.60 | 53 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $687.19 | 40 | $0 (2024) |
| Lilly USA, LLC | $647.16 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $568.44 | 57 | $0 (2024) |
| GlaxoSmithKline, LLC. | $394.16 | 31 | $0 (2024) |
| UCB, Inc. | $350.83 | 17 | $0 (2024) |
| Amarin Pharma Inc. | $341.89 | 20 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,192 | 66 | Amgen Inc. ($154.18) |
| 2023 | $1,168 | 68 | E.R. Squibb & Sons, L.L.C. ($140.28) |
| 2022 | $1,267 | 97 | Bayer HealthCare Pharmaceuticals Inc. ($223.57) |
| 2021 | $1,392 | 92 | Novo Nordisk Inc ($251.35) |
| 2020 | $1,416 | 100 | Novo Nordisk Inc ($223.10) |
| 2019 | $1,483 | 133 | Novo Nordisk Inc ($406.38) |
| 2018 | $1,353 | 111 | Novo Nordisk Inc ($340.90) |
| 2017 | $1,490 | 165 | Janssen Pharmaceuticals, Inc ($488.71) |
All Payment Transactions
832 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 11/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neurology | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/23/2024 | ORPHALAN INC | CUVRIOR (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Hepatology | ||||||
| 10/23/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.63 | General |
| 10/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Bone Health | ||||||
| 10/09/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Diabetes | ||||||
| 10/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Oncology | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Endocrinology | ||||||
| 09/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Neurology | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.27 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.70 | General |
| Category: Cardiovascular | ||||||
| 09/06/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $0.79 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Bone Health | ||||||
| 08/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Respiratory | ||||||
| 07/19/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Neurology | ||||||
| 07/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: EPILEPSY | ||||||
| 06/27/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,755 | 4,847 | $995,250 | $445,300 |
| 2022 | 14 | 1,673 | 4,856 | $931,250 | $406,684 |
| 2021 | 16 | 1,942 | 5,339 | $949,505 | $428,143 |
| 2020 | 16 | 2,379 | 6,683 | $1.2M | $475,937 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 235 | 1,067 | $266,750 | $105,618 | 39.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 187 | 1,268 | $202,880 | $102,727 | 50.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 292 | 408 | $142,800 | $58,757 | 41.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 412 | $78,280 | $38,536 | 49.2% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 116 | 381 | $66,675 | $37,084 | 55.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 178 | 473 | $76,450 | $31,112 | 40.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 175 | 231 | $51,975 | $21,909 | 42.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $40,950 | $16,948 | 41.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 93 | 209 | $26,125 | $12,850 | 49.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 146 | 168 | $21,840 | $11,272 | 51.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 46 | 73 | $10,900 | $5,128 | 47.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 31 | $9,625 | $3,359 | 34.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 224 | 1,695 | $271,200 | $119,598 | 44.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 224 | 954 | $238,500 | $81,955 | 34.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 270 | 349 | $122,150 | $57,535 | 47.1% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 110 | 413 | $61,950 | $43,882 | 70.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 442 | $83,980 | $41,356 | 49.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 159 | 330 | $49,500 | $19,741 | 39.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 146 | 167 | $37,575 | $14,708 | 39.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 146 | 167 | $20,040 | $10,078 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 171 | $25,650 | $9,873 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 25 | 25 | $8,125 | $3,481 | 42.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 30 | 42 | $5,250 | $1,626 | 31.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 39 | $1,170 | $1,147 | 98.0% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2022 | 23 | 23 | $4,600 | $881.43 | 19.2% |
About Dr. Nausheen Hasan, M.D
Dr. Nausheen Hasan, M.D is a Internal Medicine healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245321207.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nausheen Hasan, M.D has received a total of $10,761 in payments from pharmaceutical and medical device companies, with $1,192 received in 2024. These payments were reported across 832 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($10,385).
As a Medicare-enrolled provider, Hasan has provided services to 7,749 Medicare beneficiaries, totaling 21,725 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Carol Stream, IL
- Active Since 09/27/2006
- Last Updated 02/07/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245321207
Products in Payments
- Ozempic (Drug) $900.09
- XARELTO (Drug) $781.79
- APTIOM (Drug) $531.70
- ELIQUIS (Drug) $520.62
- Victoza (Drug) $397.66
- Vascepa (Drug) $341.89
- TRULICITY (Drug) $331.16
- EVENITY (Biological) $328.26
- Kerendia (Drug) $319.65
- FARXIGA (Drug) $281.24
- REXULTI (Drug) $253.01
- TRELEGY ELLIPTA (Drug) $239.38
- INVOKANA (Drug) $220.96
- Briviact (Drug) $220.44
- SYMBICORT (Drug) $204.78
- Tresiba (Drug) $185.69
- ENTRESTO (Drug) $177.08
- TOUJEO (Drug) $165.59
- Rybelsus (Drug) $157.90
- CHANTIX (Drug) $155.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Carol Stream
Susan Ignatius, Md, MD
Internal Medicine — Payments: $3,055
Angelo Miele, Md, MD
Internal Medicine — Payments: $1,878
Lawrence Schouten, Md, MD
Internal Medicine — Payments: $1,441
Mark Bednard, Do, DO
Internal Medicine — Payments: $1,380
Asad Rafiq, Md, MD
Internal Medicine — Payments: $1,271
Evelyn Diaz-Jimenez, M.d, M.D
Internal Medicine — Payments: $437.60